Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB11AP2 is a pseudogene—a DNA sequence similar to the protein-coding RAB11A gene but not known to encode a functional protein. It does not act as a therapeutic target, and there are no recorded biological functions, disease associations, or known drug interactions for this pseudogene. The primary RAB11A gene (distinct from RAB11AP2) encodes a protein involved in vesicle trafficking and cellular transport, but RAB11AP2 only resembles this gene and is classified as a pseudogene—lacking protein product and biological activity. There is no evidence this pseudogene is associated with therapeutic intervention, drug targeting, disease, or biomarker use. No relevant molecular classification categories such as "Receptor", "Enzyme", "Transporter" apply to this pseudogene. This entity is problematic for drug targeting, as a pseudogene is not a functional molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB11A, member RAS oncogene family pseudogene 2 (RAB11AP2).